Adamas Pharmaceuticals

Adamas is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). We achieve this by enhancing the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products.
Emeryville, US
Size (employees)
62 (est)+32%
Adamas Pharmaceuticals was founded in 2002 and is headquartered in Emeryville, US

Key People at Adamas Pharmaceuticals

William Dawson

William Dawson

David Mahoney

David Mahoney

David Chernoff

David Chernoff

Chief Medical Officer
Gopi Kurse

Gopi Kurse

VP of Quality Assurance
Mary Jean Stempien

Mary Jean Stempien

VP, Clinical Research
Anthony M. Rimac

Anthony M. Rimac

Chief Financial Officer & SVP Corporate Development

Adamas Pharmaceuticals Office Locations

Adamas Pharmaceuticals has office in Emeryville
Emeryville, US

Adamas Pharmaceuticals Metrics

Adamas Pharmaceuticals Summary

Market capitalization

$378 M

Closing share price

Adamas Pharmaceuticals's current market capitalization is $378 M.

Adamas Pharmaceuticals Financials

Adamas Pharmaceuticals's revenue is $1.92 M in FY, 2015 which is a 96.57% decrease from the previous period.
FY, 2015FY, 2014


$1.92 M$55.8 M

Revenue growth, %


Operating income

$-57.4 M$18.5 M

Operating expense total

$59.4 M$37.3 M

Net Income

$-51.8 M$10.2 M

Operating cash flow

$-28.3 M$-24.2 M

Adamas Pharmaceuticals Market Value History

We estimate that Adamas Pharmaceuticals's current employees are approximately 32% female and 68% male.

Adamas Pharmaceuticals Company Life

You may also be interested in